Erisha Lifescience Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-12-2024
- Paid Up Capital ₹ 0.50 M
as on 16-12-2024
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 42.77%
(FY 2017)
- Profit -69.72%
(FY 2017)
- Ebitda -56.25%
(FY 2017)
- Net Worth 5.93%
(FY 2017)
- Total Assets 5.00%
(FY 2017)
About Erisha Lifescience
The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Anshuman Tiwari, Gautam Mishra, and Vinayakumar Tiwari serve as directors at the Company.
- CIN/LLPIN
U85100MH2014PTC252083
- Company No.
252083
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jan 2014
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Erisha Lifescience?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anshuman Tiwari  | Director | 01-Dec-2022 | Current |
| Gautam Mishra | Director | 22-Nov-2022 | Current |
| Vinayakumar Tiwari | Director | 22-Nov-2022 | Current |
Financial Performance and Corporate Structure Insights of Erisha Lifescience.
Erisha Lifescience Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 42.77% increase. The company also saw a substantial fall in profitability, with a 69.72% decrease in profit. The company's net worth moved up by a moderate rise of 5.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Erisha Lifescience?
In 2017, Erisha Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Prakosh Wellness Private LimitedActive 4 years 11 months
Gautam Mishra and Vinayakumar Tiwari are mutual person
- Erisha Remedies Private LimitedActive 4 years 6 months
Gautam Mishra and Vinayakumar Tiwari are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Erisha Lifescience?
Erisha Lifescience has a workforce of 15 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Erisha Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Erisha Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
